fda tirzepatide shortage says that the GLP-1 is over GLP-1 Saga Continues: FDA Ends
Description
By Madilyn Moeller, Marketing Content Coordinator In an April 24, [...]

Semaglutide is a glucagon-like peptide 1 or GLP 1 analog injection used to treat type 2 diabetes and obesity

Conveniently place tablet under the tongue

Dispensed in a 30mL, plastic, multi-dose vial

One-and-done behavior is especially common among obesity patients, as 19% of obesity GLP-1 users fill only a single prescription
